Serotonin syndrome associated with the use of escitalopram.

  title={Serotonin syndrome associated with the use of escitalopram.},
  author={Matthew T Huska and Glenn Catalano and Maria C. Catalano},
  journal={CNS spectrums},
  volume={12 4},
Escitalopram is the newest selective serotonin reuptake inhibitor (SSRI) available for use in the United States. It has been approved for the treatment of major depression and generalized anxiety disorder. It is the S-enantiomer of the SSRI citalopram and is highly serotonin specific as it has minimal effect on the reuptake of dopamine or norepinephrine. It is also a well-tolerated medication, with a side-effect profile comparable to the other SSRIs. While a number of side effects have been… CONTINUE READING